18F-FDG PET/CT-related metabolic parameters and their value in early prediction of chemotherapy response in a VX2 tumor model

Nucl Med Biol. 2010 Apr;37(3):327-33. doi: 10.1016/j.nucmedbio.2009.12.002. Epub 2010 Jan 15.

Abstract

Objective: This study acquired fluorine-18-deoxyglucose (FDG) kinetic parameters prior and subsequent to cisplatin chemotherapy so as to define the optimal parameters for early prediction of chemotherapy response.

Methods: A total of 12 non-tumor-bearing rabbits were used to obtain noninvasive input function, five VX2 tumor-bearing rabbits were used for validation and 32 tumor-bearing rabbits underwent 4 mg kg(-1) cisplatin chemotherapy. Dynamic FDG PET/CT was performed at pretherapy, Day 0, Day 1, Day 7 and Day 14 after cisplatin administration. With the application of a three-compartment model, influx index (Ki), k1, k2, k3 and k4 were noninvasively obtained.

Results: Sensitive (SG) and insensitive groups (ISG) were defined based on their volume on Day 7. k1, Ki, SUVmean, and SUVmax showed significant decreases in SG vs. ISG at Day 0 (P<.076-0.0001). k1 demonstrated sustained (up to Day 7) differences (P<.028-0.0072), and k2, k3 and k4 showed no significant differences at any time point (P>.05). Soon after cisplatin administration, GLUT-1 expression was greatly decreased in SG vs. ISG.

Conclusions: The parameters of SUVmax, SUVmean, Ki and k1 were valuable for the early prediction of chemotherapy response. k1 had a wider observation window compared to SUVmean, SUVmax and Ki, and k1 also reflected the changes in GLUT-1 expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Cisplatin / administration & dosage*
  • Computer Simulation
  • Fluorodeoxyglucose F18 / pharmacokinetics*
  • Humans
  • Image Enhancement / methods
  • Image Interpretation, Computer-Assisted / methods*
  • Liver Neoplasms, Experimental / diagnosis*
  • Liver Neoplasms, Experimental / drug therapy*
  • Liver Neoplasms, Experimental / metabolism
  • Metabolic Clearance Rate
  • Models, Biological
  • Positron-Emission Tomography / methods
  • Rabbits
  • Radiopharmaceuticals / pharmacokinetics
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Subtraction Technique
  • Tissue Distribution
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Cisplatin